The strategy still being pursued by the CDC and FDA seems to be the pie strategy - every BP with a Covid vaccine or treatment gets a slice and a Good Luck pat on the back. The problem is too big and the supplies of therapies is too small.

As the virus mutates and the immunity people might have for a while wanes, the Pandemic landscape keeps shifting. Mutations are shared worldwide because gov'ts won't stop travel and enforce requisite quarantines.

Cytodyn's slice, as well as it can be handled by Leronlimab, still is a treatment, not a way to bring the virus to bay. Taking dying off the table is good but doesn't stop the long hauler problem - again, a treatment, not a cure.

It could work like a vaccine, a prophylactic, but the supply needed for that is almost unimaginable.

I keep thinking of my post 66056 and the research done at the New York Genomic Center, a very capable outfit. It has five Nobel Laureates on its staff and more who are the brightest of the bright in genetic research.

Here is a new news article on some of their recent activity -

https://www.nygenome.org/drs-michael-zody-and...s-feature/

I really hope they come up with more insights on how to prevent viral infection thru the ACE-2 receptors on lung epithelial cells. Would help against a lot of pathogens that exploit that entry point.

This article points out that we have a long way to go in a planned, coordinated counter offensive against the virus in spite of how devastating it is to us.

NYGC, for example, says they could test hundreds of thousand of samples a day for virus mutations. But their capabilities are not really being tapped, on testing or, more importantly, research.

Take amlodipine if you have high blood pressure. Hopefully there are other ways to frustrate the virus.

Maybe testing can be done to determine what percentage of the population can genetically handle the virus and the Cytokine Storm and save the vaccines for the rest - would help with supply maybe.

Normalcy looks a long way off!